GPCR

Structure Therapeutics Inc., trading under the ticker GPCR, is being watched by investors tracking its stock price, quotes and recent company news. The clinical-stage biotech, which develops oral treatments for metabolic conditions, has become a point of interest among traders following biotechnology movers. Details on what specifically drove the latest trading activity remain limited.